Vann P. Parker
- Molecular Biology top 10%
- Genetics top 10%
- Cellular and Molecular Neuroscience top 10%
- Oncology
- Immunology
- Co-authors
- Pamela L. MellonYakov GluzmanTom ManiatisS FalkenthalNorman DavidsonWilliam MattoxMichael W. LiebermanHsieng S. Lu
- Topics
- RNA and protein synthesis mechanisms (5 papers)RNA Research and Splicing (5 papers)Monoclonal and Polyclonal Antibodies Research (3 papers)
- Partner nations
- United StatesJapanSwitzerland
In The Last Decade
Vann P. Parker
18 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Molecular Biology 1.0k
- Genetics 288
- Cellular and Molecular Neuroscience 225
- Oncology 191
- Immunology 180
Countries citing papers authored by Vann P. Parker
This map shows the geographic impact of Vann P. Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vann P. Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vann P. Parker more than expected).
Fields of papers citing papers by Vann P. Parker
This network shows the impact of papers produced by Vann P. Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vann P. Parker. The network helps show where Vann P. Parker may publish in the future.
Co-authorship network of co-authors of Vann P. Parker
This figure shows the co-authorship network connecting the top 25 collaborators of Vann P. Parker. A scholar is included among the top collaborators of Vann P. Parker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vann P. Parker. Vann P. Parker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 52 | |
| 2 | 23 | |
| 3 | 29 | |
| 4 | 31 | |
| 5 | Pharmacokinetics and tolerability of an antiangiogenic ribozyme (ANGIOZYME) in healthy volunteers. | 38 |
| 6 | 14 | |
| 7 | 55 | |
| 8 | 57 | |
| 9 | 33 | |
| 10 | 194 | |
| 11 | 32 | |
| 12 | 25 | |
| 13 | 89 | |
| 14 | 67 | |
| 15 | 60 | |
| 16 | 24 | |
| 17 | Identification of DNA sequences required for transcription of the human α1-globin gene in a new SV40 host-vector systembreakdown → | 561 |
| 18 | 28 |
About Vann P. Parker
Vann P. Parker is a scholar working on Molecular Biology, Hematology and Immunology and Allergy, having authored 18 papers that have together received 1.4k indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (5 papers), RNA Research and Splicing (5 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Molecular Biology (1.0k citations), Cellular and Molecular Neuroscience (225 citations) and Aging (20 citations). Vann P. Parker has collaborated with scholars based in United States, Japan and Switzerland. Frequent co-authors include Pamela L. Mellon, Yakov Gluzman, Tom Maniatis, S Falkenthal, Norman Davidson, William Mattox, Michael W. Lieberman, Hsieng S. Lu, Brian Varnum and Brenda Guthrie. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.